PUT - SPRINTER OPEN END - STRYKER CORP. Share Price

Certificat

DE000VM55EF1

Delayed Deutsche Boerse AG 15:53:16 27/05/2024 BST
9.59 EUR -1.13% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month+0.41%
1 month+2.43%
Date Price Change
27/05/24 9.59 -1.13%
24/05/24 9.7 -3.48%
23/05/24 10.05 +3.18%
22/05/24 9.74 -5.34%
21/05/24 10.29 +1.18%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 03:53 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55EF
ISINDE000VM55EF1
Date issued 29/11/2023
Strike 440.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 13.86
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 14.12
Lowest since issue 7.37
Spread 0.1
Spread %1.03%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus